C07K

Follow

Stats

Description

PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)

Recent Patents

Not Available
Patent #TitleFiling DateIssue DatePatent Owner
8,889,099 Methods and compositions for delivering peptides Jan 30, 13 Nov 18, 14 , MANNKIND CORPORATION
8,889,100 Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules Mar 06, 14 Nov 18, 14 , IMMUNOMEDICS, INC.
8,889,117 Modular nanoparticles for adaptable vaccines Feb 15, 08 Nov 18, 14 , YALE UNIVERSITY
8,889,121 nucleic acid Jan 21, 11 Nov 18, 14 , THE ARIZONA BOARD OF REGENTS FOR AN ON BEHALF OF ARIZONA STATE UNIVERSITY
8,889,130 Treatment of osteoarthritis and pain Feb 08, 12 Nov 18, 14 , ABBVIE INC.
8,889,131 NOTCH inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof May 01, 12 Nov 18, 14 , THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
8,889,132 Antibodies against human HIF-1α Jun 30, 11 Nov 18, 14 , MOUNT SINAI HOSPITAL
8,889,133 Methods of treating diabetes with Dll4 antagonists Jan 28, 11 Nov 18, 14 , REGENERON PHARMACEUTICALS, INC.
8,889,134 hyphal morphogenesis and uses thereof Jan 22, 13 Nov 18, 14 , AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH
8,889,135 Methods of administering anti-TNFα antibodies Jun 05, 02 Nov 18, 14 , ABBVIE BIOTECHNOLOGY LTD.
8,889,136 Multiple-variable dose regimen for treating TNFα-related disorders Apr 11, 05 Nov 18, 14 , ABBVIE BIOTECHNOLOGY LTD.
8,889,137 Anti-HSV antibody Oct 01, 10 Nov 18, 14 , UNIVERSITÄT DUISBERG ESSEN; RHEINISCHE FRIEDRICH WILHELMS —UNIVERSITÄT BONN;
8,889,138 Anti-ADDL antibodies and uses thereof Oct 11, 10 Nov 18, 14 , MERCK SHARP & DOHME CORP.; NORTHWESTERN UNIVERSITY;
8,889,140 Compositions and methods for tissue repair May 30, 08 Nov 18, 14 , TRANSTARGET, INC.; THE REGENTS OF THE UNIVERSITY OF CALIFORNIA;
8,889,142 antigens for vaccine and diagnostic use Oct 11, 05 Nov 18, 14 , STATENS SERUM INSTITUT
8,889,145 antigens Sep 20, 13 Nov 18, 14 , WYETH LLC
8,889,146 Vaccine Jun 24, 10 Nov 18, 14 , GLAXOSMITHKLINE BIOLOGICALS SA
8,889,148 Flavivirus host-range mutations and uses thereof Jun 30, 11 Nov 18, 14 , RESEARCH DEVELOPMENT FOUNDATION
8,889,150 and uses thereof Mar 17, 11 Nov 18, 14 , SOCPRA—SCIENCES ET GÉNIE, S.E.C.
8,889,345 Detection methods of NADP(H) using mBFP Dec 24, 12 Nov 18, 14 , INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY

more results

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2014/0341,801 INACTIVATION OF SMOOTH MUSCLE TISSUE Jul 30, 14 Nov 20, 14 , Not available
2014/0341,802 PROVASOPRESSIN ANTAGONISTS AND USES THEREOF May 12, 14 Nov 20, 14 , WOOMERA THERAPEUTICS, INC.
2014/0341,804 HOMOMULTIVALENT AND HETEROMULTIVALENT INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PMSA) AND USES THEREOF Nov 30, 12 Nov 20, 14 , THE JOHNS HOPKINS UNIVERSITY
2014/0341,809 High-Affinity DMF5 T Cell Receptor (TCR) Variants May 16, 14 Nov 20, 14 , UNIVERSITY OF MASSACHUSETTS; THE UNIVERSITY OF NOTRE DAME DU LAC;
2014/0341,810 ANTAGONISTS FOR ABDOMINAL VASOPRESSIN V2 RECEPTOR AND USES THEREOF May 12, 14 Nov 20, 14 , WOOMERA THERAPEUTICS, INC.
2014/0341,843 PURIFIED PROTEINS Jul 27, 12 Nov 20, 14 , ELEVEN BIOTHERAPEUTICS, INC.
2014/0341,852 CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS AND METHODS THEREFOR Mar 14, 14 Nov 20, 14 , THE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC.
2014/0341,858 NEURON GENERATION, REGENERATION AND PROTECTION Jun 23, 14 Nov 20, 14 , Not available
2014/0341,869 CHIMERIC RECEPTORS WITH 4-1BB STIMULATORY SIGNALING DOMAIN Jun 10, 14 Nov 20, 14 , Not available
2014/0341,876 METHOD FOR THE TREATMENT OF PULMONARY DISEASE AND METHOD OF PRODUCING PROTEINS OF USE THEREIN Aug 04, 14 Nov 20, 14 , THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERV
2014/0341,883 DELAMINATION RESISTANT PHARMACEUTICAL GLASS CONTAINERS CONTAINING ACTIVE PHARMACEUTICAL INGREDIENTS Apr 23, 14 Nov 20, 14 , CORNING INCORPORATED
2014/0341,884 Novel Complex Mutations in the Epidermal Growth Factor Receptor Kinase Domain Nov 01, 13 Nov 20, 14 , ROCHE MOLECULAR SYSTEMS, INC.
2014/0341,885 FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY May 02, 12 Nov 20, 14 , MILLENNIUM PHARMACEUTICALS INC.
2014/0341,887 METHODS FOR TREATING, DIAGNOSING, AND MONITORING RHEUMATOID ARTHRITIS Apr 08, 14 Nov 20, 14 , GENENTECH INC.
2014/0341,888 DELAMINATION RESISTANT PHARMACEUTICAL GLASS CONTAINERS CONTAINING ACTIVE PHARMACEUTICAL INGREDIENTS Apr 23, 14 Nov 20, 14 , CORNING INCORPORATED
2014/0341,889 DELAMINATION RESISTANT PHARMACEUTICAL GLASS CONTAINERS CONTAINING ACTIVE PHARMACEUTICAL INGREDIENTS Apr 23, 14 Nov 20, 14 , CORNING INCORPORATED
2014/0341,890 DELAMINATION RESISTANT PHARMACEUTICAL GLASS CONTAINERS CONTAINING ACTIVE PHARMACEUTICAL INGREDIENTS Apr 23, 14 Nov 20, 14 , CORNING INCORPORATED
2014/0341,891 DELAMINATION RESISTANT PHARMACEUTICAL GLASS CONTAINERS CONTAINING ACTIVE PHARMACEUTICAL INGREDIENTS Apr 23, 14 Nov 20, 14 , CORNING INCORPORATED
2014/0341,892 ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES May 19, 14 Nov 20, 14 , GLENMARK PHARMACEUTICALS SA
2014/0341,893 BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER May 28, 14 Nov 20, 14 , GENENTECH, INC.

more results

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

UPGRADE MEMBERSHIP CANCEL